Patents by Inventor Ali Fallah-Araghi

Ali Fallah-Araghi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20220235341
    Abstract: The present invention relates to alpha-amylase variants of a parent alpha-amylase wherein said alpha-amylase variants have an improved wash performance as compared to said parent alpha-amylase. The invention also relates to compositions comprising the variants of the invention, uses of said variants and methods of producing said variants.
    Type: Application
    Filed: March 20, 2020
    Publication date: July 28, 2022
    Applicant: Novozymes A/S
    Inventors: Carsten Andersen, Sofia Arnehed, Lars Lehmann Hylling Christensen, Ali Fallah-Araghi, Markus Klinger, Anders Gunnar Sandstrom
  • Droplet-based selection by injection
    Patent number: 10883102
    Abstract: A method for the identification of a polynucleotide encoding an enzyme of interest in a microfluidic device by providing an emulsion of microfluidic droplets comprising a library of polynucleotides encoding one or more enzyme, introducing a concentrated PCR solution which allows PCR amplification of the polynucleotides into selected droplets and/or introducing a lethal solution into deselected droplets, and identifying a polynucleotide encoding an enzyme of interest.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: January 5, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Ali Fallah-Araghi, Ole Skyggebjerg
  • OXIDATION STABLE ALPHA-AMYLASE VARIANTS
    Publication number: 20200399624
    Abstract: The present invention relates to oxidation stable alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 9, 2020
    Publication date: December 24, 2020
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anne Dorte Houg, Signe Eskildsen Larsen, Ali Fallah-Araghi
  • Alpha-amylase variants
    Patent number: 10428321
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: October 1, 2019
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Signe Eskildsen Larsen, Ali Fallah-Araghi
  • Droplet-Based Selection By Injection
    Publication number: 20180094255
    Abstract: A method for the identification of a polynucleotide encoding an enzyme of interest in a microfluidic device by providing an emulsion of microfluidic droplets comprising a library of polynucleotides encoding one or more enzyme, introducing a concentrated PCR solution which allows PCR amplification of the polynucleotides into selected droplets and/or introducing a lethal solution into deselected droplets, and identifying a polynucleotide encoding an enzyme of interest.
    Type: Application
    Filed: March 15, 2016
    Publication date: April 5, 2018
    Applicant: Novozymes A/S
    Inventors: Ali Fallah-Araghi, Ole Skyggebjerg
  • ALPHA-AMYLASE VARIANTS
    Publication number: 20170240877
    Abstract: The present invention relates toalpha-amylasevariants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: June 12, 2015
    Publication date: August 24, 2017
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Signe Eskildsen Larsen, Ali Fallah-Araghi
  • OXIDATION STABLE ALPHA-AMYLASE VARIANTS
    Publication number: 20170121696
    Abstract: The present invention relates to oxidation stable alpha-amylase variants. The present invention also relates to poly-nucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: June 12, 2015
    Publication date: May 4, 2017
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anne Dorte Houg, Signe Eskildsen Larsen, Ali Fallah-Araghi